Select your Country or Region

  • TargetMol | Compound LibraryArgentinaArgentina
  • TargetMol | Compound LibraryAustraliaAustralia
  • TargetMol | Compound LibraryAustriaAustria
  • TargetMol | Compound LibraryBelgiumBelgium
  • TargetMol | Compound LibraryBrazilBrazil
  • TargetMol | Compound LibraryBulgariaBulgaria
  • TargetMol | Compound LibraryCroatiaCroatia
  • TargetMol | Compound LibraryCyprusCyprus
  • TargetMol | Compound LibraryCzechCzech
  • TargetMol | Compound LibraryDenmarkDenmark
  • TargetMol | Compound LibraryEgyptEgypt
  • TargetMol | Compound LibraryEstoniaEstonia
  • TargetMol | Compound LibraryFinlandFinland
  • TargetMol | Compound LibraryFranceFrance
  • TargetMol | Compound LibraryGermanyGermany
  • TargetMol | Compound LibraryGreeceGreece
  • TargetMol | Compound LibraryHong KongHong Kong
  • TargetMol | Compound LibraryHungaryHungary
  • TargetMol | Compound LibraryIcelandIceland
  • TargetMol | Compound LibraryIndiaIndia
  • TargetMol | Compound LibraryIrelandIreland
  • TargetMol | Compound LibraryIsraelIsrael
  • TargetMol | Compound LibraryItalyItaly
  • TargetMol | Compound LibraryKoreaKorea
  • TargetMol | Compound LibraryLatviaLatvia
  • TargetMol | Compound LibraryLebanonLebanon
  • TargetMol | Compound LibraryMalaysiaMalaysia
  • TargetMol | Compound LibraryMaltaMalta
  • TargetMol | Compound LibraryMoroccoMorocco
  • TargetMol | Compound LibraryNetherlandsNetherlands
  • TargetMol | Compound LibraryNew ZealandNew Zealand
  • TargetMol | Compound LibraryNorwayNorway
  • TargetMol | Compound LibraryPolandPoland
  • TargetMol | Compound LibraryPortugalPortugal
  • TargetMol | Compound LibraryRomaniaRomania
  • TargetMol | Compound LibrarySingaporeSingapore
  • TargetMol | Compound LibrarySlovakiaSlovakia
  • TargetMol | Compound LibrarySloveniaSlovenia
  • TargetMol | Compound LibrarySpainSpain
  • TargetMol | Compound LibrarySwedenSweden
  • TargetMol | Compound LibrarySwitzerlandSwitzerland
  • TargetMol | Compound LibraryTaiwan,ChinaTaiwan,China
  • TargetMol | Compound LibraryThailandThailand
  • TargetMol | Compound LibraryTurkeyTurkey
  • TargetMol | Compound LibraryUnited KingdomUnited Kingdom
  • TargetMol | Compound LibraryUnited StatesUnited States
  • TargetMol | Compound LibraryOther CountriesOther Countries
Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty

Androgen Receptor

The androgen receptor (AR), also known as NR3C4 (nuclear receptor subfamily 3, group C, member 4), is a type of nuclear receptor that is activated by binding any of the androgenic hormones, including testosterone and dihydrotestosterone in the cytoplasm and then translocating into the nucleus.

  • Enzalutamide
    T6002915087-33-1
    Enzalutamide (MDV3100) is an androgen receptor (AR) antagonist (IC50=36 nM in LNCaP). Enzalutamide activates autophagy, has antitumor activity, and is commonly used in the treatment of desmoplasia-resistant prostate cancer.
    • $40
    In Stock
    Size
    QTY
    TargetMol | Inhibitor Hot
    TargetMol | Citations Cited
  • Medroxyprogesterone Acetate
    T126171-58-9
    Medroxyprogesterone Acetate (Farlutin) is a synthetic progestin that is derived from 17-hydroxyprogesterone. It is a long-acting contraceptive that is effective both orally or by intramuscular injection and has also been used to treat breast and endometrial neoplasms.
    • $30
    In Stock
    Size
    QTY
    TargetMol | Citations Cited
  • Allura Red AC
    TN137025956-17-6
    Allura Red AC (CI 16035) is a very important food azo dye used in the food, pharmaceutical, paper, cosmetic and textile industries.Allura Red AC promotes susceptibility to experimental colitis via mouse intestinal serotonin.
    • $50
    In Stock
    Size
    QTY
  • CSRM617 hydrochloride
    T10896L1353749-74-2In house
    CSRM617 hydrochloride is a selective small-molecule inhibitor of the transcription factor ONECUT2 ( OC2, a master regulator of androgen receptor) with a K d of 7.43 uM in SPR assays, directly binds to OC2-HOX domain. CSRM617 hydrochloride induces apoptosis through the appearance of cleaved Caspase-3 and PARP. CSRM617 hydrochloride is well tolerated in the mouse model of prostate cancer [1]
    • $56
    In Stock
    Size
    QTY
  • Protodioscin
    T232155056-80-9
    Protodioscin (Furostanol I) is a major steroidal saponin in dioscoreae rhizome, with anti-hyperlipidemia, anti-cancer properties.
    • $110
    In Stock
    Size
    QTY
  • Testosterone propionate
    T041957-85-2
    Testosterone Propionate is a short acting oil-based injectable formulation of testosterone. Testosterone inhibits gonadotropin secretion from the pituitary gland and ablates estrogen production in the ovaries, thereby decreasing endogenous estrogen levels.
    • $50
    In Stock
    Size
    QTY
  • S-23
    T207891010396-29-8
    S-23 ((S)-3-(4-chloro-3-fluorophenoxy)-N-(4-cyano-3-(trifluoromethyl)phenyl)-2-hydroxy-2-methylpropanamide) is an oral selective androgen receptor modulator (SARM) with a Ki of 1.7 nM. S-23 increases prostate, seminal vesicle, and levator ani muscle weights in castrated rats.
    • $39
    In Stock
    Size
    QTY
  • Ostarine
    T2408841205-47-8
    Ostarine (MK-2866) is a non-steroidal agent with anabolic activity. Selective androgen receptor modulator (SARM) GTx-024 is designed to work like testosterone, thus promoting and/or maintaining libido, fertility, prostate growth, and muscle growth and strength. Mimicking testosterone's action, this agent may increase lean body mass, thereby ameliorating muscle wasting in the hypermetabolic state of cancer cachexia.
    • $36
    In Stock
    Size
    QTY
  • Spironolactone
    T047652-01-7
    Spironolactone (SC9420) is an Aldosterone Antagonist. The mechanism of action of spironolactone is as an Aldosterone Antagonist.
    • $33
    In Stock
    Size
    QTY
    TargetMol | Citations Cited
  • Adrenosterone
    T2207382-45-6
    Adrenosterone (11-ketoandrostenedione) is a steroid hormone isolated from the adrenal cortex.
    • $39
    In Stock
    Size
    QTY
  • JNJ-63576253 free base
    T89332110426-27-0
    JNJ-63576253 free base (TRC253) is a potent and orally active full antagonist of androgen receptor (AR), with IC50s of 37 and 54 nM for F877L mutant AR and wild-type AR in LNCaP cells. JNJ-63576253 can be used for the research of castration-resistant prostate cancer (CRPC).
    • $41
    In Stock
    Size
    QTY
  • AS-601811
    T30150194979-95-8
    AS-601811 is a steroidal 5α-reductase inhibitor and androgen receptor modulator used to study hair loss and acne.
    • $293
    In Stock
    Size
    QTY
  • BMS-641988
    T67818 In house
    BMS-641988 is a novel nonsteroidal androgen receptor antagonist for the treatment of prostate cancer.
    • $163
    In Stock
    Size
    QTY
  • CTK8A3536
    T8592926228-58-2
    CTK8A3536 ((2-MORPHOLIN-4-YL-4-PHENYL-1,3-THIAZOL-5-YL)METHANOL) is an inhibitor of Androgen receptor.
    • $133
    In Stock
    Size
    QTY
    TargetMol | Inhibitor Sale
  • RU 59063
    T20761155180-53-3
    RU 59063 is a prototype of a new class of high-affinity nonsteroidal androgen receptor (AR) ligands.
    • $148
    In Stock
    Size
    QTY
    TargetMol | Inhibitor Sale
  • AR antagonist 1
    T103591818885-54-9
    AR antagonist 1 is a potent antagonist of the androgen receptor. It binds to E3 ligase ligands with weak binding affinities to VHL protein in the synthesis of PROTAC ARD-266.
    • $133
    In Stock
    Size
    QTY
    TargetMol | Inhibitor Sale
  • 3-(7,7-dimethyl-5-oxo-6,7-dihydro-5H-pyrrolo[3,4-b]pyridin-2-yl)-1H-indole-7-carbonitrile
    T97522759137-87-4In house
    3-[7 ,7- dimethyl-5-oxo -6H-pyrrolo[3,4-b]pyridin-2-yI]-1H-indole-7 -carbonitrile is an androgen receptor modulator.
    • $148
    In Stock
    Size
    QTY
    TargetMol | Inhibitor Sale
  • MK-0773 FA
    T16090L In house
    MK-0773 FA (MK-0773 FA (606101-58-0 Free base)) is a selective androgen receptor modulator with an IC50 value of 6.6 nM for AR, which can be used for the prevention and treatment of cancer-related muscle wasting.
    • $79
    In Stock
    Size
    QTY
    TargetMol | Inhibitor Sale
  • Ralaniten triacetate
    T363751637573-04-6In house
    Ralaniten triacetate (EPI-506), a precursor of Ralaniten, is a first-of-its-kind, orally active androgen receptor N-terminal structural domain (AR-NTD) inhibitor with anticancer activity and can be used to study prostate and breast cancer.
    • $165 TargetMol
    In Stock
    Size
    QTY
    TargetMol | Inhibitor Sale
  • VPC-13566
    T29111218464-59-6In house
    VPC-13566 is a BF3-specific small molecule, which effectively inhibited the androgen receptor transcriptional activity and displaced the BAG1L peptide from the BF3 pocket. VPC-13566 inhibits the growth of various prostate cancer cell lines and reduces the growth of AR-dependent prostate cancer xenograft tumors in mice.
    • $40
    In Stock
    Size
    QTY
  • MK-0773
    T16090606101-58-0In house
    MK-0773 (PF-05314882) is a selective androgen receptor modulator that binds to AR (IC50: 6.6 nM) for the study of diseases caused by endocrine abnormalities.
    • $78 TargetMol
    In Stock
    Size
    QTY
  • Ralaniten
    T285021203490-23-6In house
    Ralaniten (EPI-002) is a potent, specific, and orally active antagonist of the androgen receptor N-terminal structural domain (AR-NTD).Ralaniten inhibits AR transcriptional activity with an IC50 value of 7.4 μM.Ralanites have anticancer activity and can be used to study desmoplasia-resistant prostate cancer (CRPC).
    • $34
    In Stock
    Size
    QTY
    TargetMol | Inhibitor Sale
  • Lupeol
    T2895545-47-1
    Lupeol (Monogynol B) is a novel androgen receptor inhibitor with anti-inflammatory and antioxidant activity.
    • $30
    In Stock
    Size
    QTY
    TargetMol | Citations Cited
  • 2-hydroxy Flutamide
    T769052806-53-8
    2-hydroxy Flutamide is competitive inhibition of androgen receptor (AR) for the treatment of prostate cancer
    • $47
    In Stock
    Size
    QTY
    TargetMol | Inhibitor Sale
  • AC-262536
    T26539870888-46-3
    AC-262536 is a selective androgen receptor (SAR) modulator. It has partial agonist activity with respect to testosterone and suppresses luteinizing hormone.
    • $39
    In Stock
    Size
    QTY
    TargetMol | Inhibitor Sale
  • ACP-105
    T14116899821-23-9
    ACP-105 is a novel and potent nonsteroidal selective androgen receptor modulator (SARM) with partial agonist activity relative to the natural androgen testosterone.
    • $38
    In Stock
    Size
    QTY
    TargetMol | Inhibitor Sale
  • Andarine
    T2108401900-40-1
    Andarine (GTx-007) (S-4) is an active partial agonist and an investigational selective androgen receptor modulator (SARM).
    • $30
    In Stock
    Size
    QTY
    TargetMol | Inhibitor Sale
  • Androgen receptor degrader-1
    T806332616553-35-4
    Androgen Receptor Degrader-1 (Compound 18) is a potent agent for androgen receptor degradation, applicable in cancer research [1].
    • Inquiry Price
    Size
    QTY
    TargetMol | Inhibitor Sale
  • Androgen receptor degrader-2
    T806472616553-33-2
    Androgen Receptor Degrader-2 (Compound 9) is a potent degrader of androgen receptors, with potential application in cancer research [1].
    • Inquiry Price
    Size
    QTY
    TargetMol | Inhibitor Sale
  • p,p'-DDE
    T744072-55-9
    p,p'-DDE (p,p'-dichlorodiphenyldichloroethylene) is a metabolite and degradation product of the organochlorine pesticide DDT
    • $58
    In Stock
    Size
    QTY
    TargetMol | Inhibitor Sale
  • MI-136
    T68891628316-74-4
    MI-136 inhibits expression of androgen receptor (AR) target genes that DHT induced.
    • $39
    In Stock
    Size
    QTY
    TargetMol | Inhibitor Sale
  • Nandrolone propionate
    T194707207-92-3
    Nandrolone propionate is an anabolic steroid action primarily consisting of androgenic and nitrogen-retentive properties.
    • $50
    In Stock
    Size
    QTY
    TargetMol | Inhibitor Sale
  • N-Nitrosodicyclohexylamine
    T81662947-92-2
    N-Nitrosodicyclohexylamine (NDCHA), an N-nitrosocompound, exhibits anti-androgenic activity by competitively binding to the androgen receptor (AR) in opposition to 5α-dihydrotestosterone and reducing AR protein levels [1].
    • Inquiry Price
    Size
    QTY
    TargetMol | Inhibitor Sale
  • Androgen receptor antagonist 9
    T83119915086-32-7
    Androgen Receptor Antagonist 9 (compound 28) serves as an antagonist to the androgen receptor [1].
    • Inquiry Price
    Size
    QTY
    TargetMol | Inhibitor Sale
  • Metenolone acetate
    T8117434-05-9
    Metenolone acetate (Methenolone acetate) is an androgen and anabolic steroid (AAS) medication which is used mainly in the treatment of anemia due to bone marrow failure.
    • $11,500
    In Stock
    Size
    QTY
    TargetMol | Inhibitor Sale
  • Physalin A
    TN477423027-91-0
    Physalin A exerts anti-tumor activity in non-small cell lung cancer cell lines by suppressing JAK/STAT3 signaling, it inhibits androgen-independent prostate cancer cell growth through activation of cell apoptosis and downregulation of androgen receptor ex
    • $998
    Backorder
    Size
    QTY
    TargetMol | Inhibitor Sale
  • Ganoderic acid DM
    TN1663173075-45-1
    Ganoderic acid DM is an antiandrogenic osteoclastogenesis inhibitor, it especially suppresses the expression of c-Fos and nuclear factor of activated T cells c1 (NFATc1), this suppression leads to the inhibition of dendritic cell-specific transmembrane pr
    • $275
    35 days
    Size
    QTY
    TargetMol | Inhibitor Sale
  • Ligandrol
    T157501165910-22-4
    Ligandrol is a novel nonsteroidal, oral SARM that binds to the androgen receptor with high affinity (Ki: 1 nM) and selectivity.
    • $40
    In Stock
    Size
    QTY
    TargetMol | Inhibitor Sale
  • (R)-SKBG-1
    T79156
    (R)-SKBG-1 is an inhibitor of the RNA-binding protein NONO, effectively downregulating androgen receptor expression by targeting both AR-FL mRNA and AR-V7 mRNA, with inhibition concentration (IC50) values of 3.1 μM and 5.5 μM, respectively [1].
    • Inquiry Price
    Size
    QTY
    TargetMol | Inhibitor Sale
  • GSK-2881078
    T36181539314-06-1
    GSK-2881078 is a selective androgen receptor modulator (SARM) that is being evaluated for effects on muscle growth and strength in subjects with muscle wasting to improve their physical function.
    • $64
    In Stock
    Size
    QTY
    TargetMol | Inhibitor Sale
  • Seviteronel
    T13312L1610537-15-9
    Seviteronel (VT-464) is a novel CYP17 cleavage enzyme inhibitor and androgen receptor antagonist for the study of breast and prostate cancer.
    • $198
    In Stock
    Size
    QTY
  • Galloylpaeoniflorin
    TN1067122965-41-7
    Galloylpaeoniflorin (6'-O-Galloyl paeoniflorin) may be developed as a cytoprotector against ROS-mediated oxidative stress. Galloylpaeoniflorin is also an inhibtior of NF-κB and DNA cleavage.
    • $148
    In Stock
    Size
    QTY
  • LGD-3303
    T843151196133-39-7
    LGD-3303 is an orally available and selective androgen receptor modulator.
      Inquiry
    • BMS-986365
      T842972446928-30-7
      BMS-986365 (CC-94676) is an orally available, selective and highly potent AR degrader with potential anticancer activity that inhibits AR signaling and suppresses tumor growth for the study of prostate cancer.
      • $193
      In Stock
      Size
      QTY
    • ARD-1676
      T797252632305-36-1
      ARD-1676 is an orally administered androgen receptor (AR) PROTAC degrader that combines an AR ligand with a cereblon ligand. It demonstrates AR-degrading activity both in vitro and in vivo, and effectively inhibits VCaP tumor growth in mouse xenograft models [1].
      • Inquiry Price
      Size
      QTY
    • Apalutamide
      T2339956104-40-8
      Apalutamide (ARN-509) is a small molecule and androgen receptor (AR) antagonist with potential antineoplastic activity.
      • $48
      In Stock
      Size
      QTY
    • Chlormadinone acetate
      T1596302-22-7
      Chlormadinone acetate (Gestafortin) is an orally active synthetic progestational hormone used often in combinations as an oral contraceptive.
      • $39
      In Stock
      Size
      QTY
    • Dimethylcurcumin
      TQ021452328-98-0
      Dimethylcurcumin (ASC-J9) (ASC-J9) is an androgen receptor degradation enhancer. It effectively suppresses castration-resistant prostate cancer cell proliferation and invasion.
      • $130
      In Stock
      Size
      QTY
    • Galeterone
      T6509851983-85-2
      Galeterone (VN 124) is an orally bioavailable small-molecule androgen receptor modulator and CYP17 lyase inhibitor with potential antiandrogen activity. Galeterone exhibits three distinct mechanisms of action: 1) as an androgen receptor antagonist, 2) as a CYP17 lyase inhibitor and 3) by decreasing overall androgen receptor levels in prostate cancer tumors, all of which may result in a decrease in androgen-dependent growth signaling. Localized to the endoplasmic reticulum (ER), the cytochrome P450 enzyme CYP17 (P450C17 or CYP17A1) exhibits both 17alpha-hydroxylase and 17, 20-lyase activities, and plays a key role in the steroidogenic pathway that produces progestins, mineralocorticoids, glucocorticoids, androgens, and estrogens.
      • $52
      In Stock
      Size
      QTY
      TargetMol | Citations Cited
    • Topterone
      T1318760607-35-4
      Topterone (Win 17,665) is a potent topical antiandrogen that inhibits the stimulation of lumbar organ development by testosterone and dihydrotestosterone in castrated immature male hamsters.
      • $700
      Backorder
      Size
      QTY